• 1. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 2. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 3. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
• 4. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Professional Introduction to N-Cyclopropyl 4-bromo-2-nitroaniline (CAS No. 887351-39-5)

N-Cyclopropyl 4-bromo-2-nitroaniline, with the chemical formula C⁸H₆BrN₂O₂, is a significant compound in the field of pharmaceutical and chemical research. This compound, identified by its unique CAS number 887351-39-5, has garnered attention due to its structural features and potential applications in the development of novel therapeutic agents. The presence of both a cyclopropyl group and a nitro substituent on aniline provides a rich framework for further chemical modifications and biological evaluations.

The structural motif of N-Cyclopropyl 4-bromo-2-nitroaniline consists of a benzene ring substituted with a bromine atom at the 4-position and a nitro group at the 2-position, with an N-cyclopropyl amine attached to the nitrogen atom of the aniline ring. This specific arrangement imparts unique electronic and steric properties to the molecule, making it a valuable intermediate in synthetic chemistry. The bromo and nitro functional groups are particularly noteworthy, as they serve as versatile handles for further derivatization, enabling the synthesis of a wide array of pharmacologically relevant compounds.

In recent years, there has been growing interest in exploring the pharmacological potential of nitroaromatic compounds, including derivatives of aniline. The nitro group can be readily reduced to an amine, which is a common strategy in drug development to enhance solubility and bioavailability. Additionally, the bromine atom can participate in cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, facilitating the introduction of diverse substituents onto the aromatic core. These reactivity patterns make N-Cyclopropyl 4-bromo-2-nitroaniline a promising building block for constructing complex molecular architectures.

One of the most compelling aspects of N-Cyclopropyl 4-bromo-2-nitroaniline is its potential application in the discovery of novel bioactive molecules. Recent studies have highlighted the importance of aniline derivatives in various therapeutic areas, including anticancer, antimicrobial, and anti-inflammatory agents. The cyclopropyl group, in particular, has been shown to influence both the electronic properties and metabolic stability of drug candidates. By incorporating this moiety into pharmacophores, researchers aim to enhance binding affinity and reduce susceptibility to enzymatic degradation.

The synthesis of N-Cyclopropyl 4-bromo-2-nitroaniline involves a multi-step process that typically begins with the bromination of 2-nitroaniline followed by introduction of the cyclopropyl group via nucleophilic substitution or other coupling strategies. The precise synthetic route can vary depending on the desired purity and scale of production. Advanced techniques such as flow chemistry have been employed to optimize reaction conditions and improve yields. These advancements contribute to making high-quality intermediates like N-Cyclopropyl 4-bromo-2-nitroaniline more accessible for research purposes.

The biological evaluation of N-Cyclopropyl 4-bromo-2-nitroaniline has revealed several intriguing properties. Preliminary studies suggest that this compound exhibits moderate activity against certain bacterial strains, likely due to its ability to disrupt essential metabolic pathways. Additionally, its structural features may confer favorable pharmacokinetic properties, such as improved oral bioavailability and prolonged half-life. These findings underscore the importance of exploring structurally diverse compounds like N-Cyclopropyl 4-bromo-2-nitroaniline for identifying new therapeutic leads.

In conclusion, N-Cyclopropyl 4-bromo-2-nitroaniline (CAS No. 887351-39-5) represents a fascinating compound with significant potential in pharmaceutical research. Its unique structural features, combined with its reactivity patterns, make it a valuable intermediate for synthesizing novel bioactive molecules. As our understanding of drug design continues to evolve, compounds like N-Cyclopropyl 4-bromo-2-nitroaniline will undoubtedly play a crucial role in discovering next-generation therapeutic agents.

• 59504-32-4(Pyrrolidine, 1-(4-bromo-2-nitrophenyl)-)
• 813448-98-5(N-Ethyl 5-bromo-2-nitroaniline)
• 1135351-95-9(4-Bromo-N-(tert-butyl)-2-nitroaniline)
• 863604-71-1(5-Bromo-N-isopropyl-2-nitroaniline)
• 1396554-46-3(3-Bromo-N-cyclopropyl-2-nitrobenzenamine)
• 683274-50-2(N-Isopropyl 4-bromo-2-nitroaniline)
• 265662-22-4(Benzenamine, 4,5-dibromo-N-(2-methylpropyl)-2-nitro-)
• 1163707-73-0(5-Bromo-N-(tert-butyl)-2-nitroaniline)
• 55432-23-0(N-Cyclopropyl-2-nitroaniline)
• 56136-82-4(4-Bromo-N-ethyl-2-nitroaniline)